Cardiomyopathy plus diabetes and the heart Flashcards Preview

CAM201 Clinical Skills > Cardiomyopathy plus diabetes and the heart > Flashcards

Flashcards in Cardiomyopathy plus diabetes and the heart Deck (20)
Loading flashcards...

Definition of cardiomyopathy

Disease with the dominant feature being direct involvement of the myocardium. 


Classification of cardiomyopathy


  • Dilated
  • Hypertrophic
  • Restricted

Specific aetiology

  • Ischaemic
  • Hypertensive
  • Inflammatory
  • Alcoholic
  • Post tachycardia
  • Drug induced (e.g. daunorubicin, adriamycin, peripartum etc)
  • Related to muscular or neuromuscular diseases


Dilated cardiomyopathy

Characterised by cardiac enlargement and reduced systolic function. 

Although multiple diseases are known to cause it, most new cases are 'idiopathic'. 

All chambers (usually) enlarged with widespread fibrosis. 


Presentation of DCM

  • Symptoms of LVF principally SOBOE.
  • Incidental finding of ECG changes often LBBB. 
  • Incidental finding of big heart on CXR
  • Incidental big heart on echo or reduced LV function. 


Management of DCM

Symptomatic: treat as LVF

  • ACEI (or ARBs) and vasodilating beta blockers the key drug classes. 

Asymptomatic: treatment not certain. Generally use vasodilating beta blockers (e.g. carvedilol)


Hypertrophic cardiomyopathy

HOCM (however, not all obstructive).

Familial HOCM: autosomal dominant with variable penetrance and expression. 

  • A number of genes are involved in development of HOCM including ones affecting myosin, others tropomyosin, others troponin T etc. 
  • Many sporidic cases are presumably spontaneous mutation. 


Pathophysiology of HOCM

  • Marked LVH often mainly septal
  • Small LV cavity
  • Often systolic anterior motion of MV

Septal LVH plus contribution from the MV movement may cause significant obstruction of LV outflow tract


Symptoms of HOCM

  • Generally asymptomatic and often found by family screening after index case. 
  • Commonest symptom dyspnoea
  • Angina, palpitations, dizziness may occur.
  • Unfortunately sudden death may be first symptom or event


Examintion findings in HOCM

  • Forceful apex beat sometimes a double impulse (palpable 'a' wave). 
  • Carotid pulse 'jerky'
  • Often 4th heart sound
  • Mid-systolic murmur that changes with 'vaso-active' manouvres; increases with those that reduce venous return (smaller cavity magnifies LV outflow gradient) and decreases if LV volume increases. 
  • Longer systolic mumur if MR also present. 


Complications of HOCM

  • Sudden cardiac death (Commonest cause of SCD in adolescents)
  • Ventricular and SV dysrhythmias
  • CCD
  • Mitral regurgitation
  • Infective endocarditis
  • AF tolerated poorly


Management of HOCM

  • Echo confirms diagnosis
  • NO hihly competitive sports
  • If significantly symptomatic with LVOT gradient beta block and add if needed Ca channel blocker that reduces contractility such as verapamil
  • These drug classes reduce contractility and lessen the LVOT gradient
  • If gradient very large and patient very symptomatic surgical myomectomy (septal artery ablation sometimes used). 
  • Defibrillator for patients at high risk of SCD


Restrictive cardiomyopathy

Also called infiltrative cardiomyopathy

Least common form of CM. 

Management very difficult. 


Restrictie CM aetiology

Amyloid, sarcoid and 'idiopathic' most common aetiologies. 

Often hard to diagnose aetiology, sometimes requiring biopsy and even then not always helpful. 


Restrictive CM pathophysiology

Principal pathophysiology is diastolic dysfunction and sometimes there is minimal systolic dysfunction. 


Type I diabetes and CVD risk

Increased CVD risk appears related to increased weight gain particularly central adiposity (?) due to peripheral hyperinsulinaemia. 

Risk is increased because of adverse effects of diabetic microangiopathy especially renal. 


Type II diabetes and CVD risk

CVD rates are 4-10x higher than those od nondiabetics. 

  • Metabolic syndrome with lipid abnormalities (high LDL, low HDL, high triglycerides) common. 
  • HTN common
  • CVD remains high even with tight control of lipids and BP. 
  • Same risk fo MI as someone with known CAD


Why are type II diabetic at increased with of CVD?

  • Increased prothrombotic state
  • Stickier platelets
  • Increased endothelial dysfunction
  • Xs smooth muscle proliferation


Features of diabetic CAD

  • Greater atheromatous plaque burden
  • Smaller vessel size
  • Disease more diffuse with longer narrowings
  • Generally mutiple arteries involved


Management of diabetic CAD

  • Rigid control of lipids and BP
  • No evidence that rigid control of glycaemia improves outcome and some to the contrary
  • ACEI and ARBs for BP control
  • Standard treatment for angina with exception of revascularisation choices; CABG better than PCI
  • Higher restonosis rates with PCI


Diabetic cardiomyopathy definition, characteristics and management. 

  • Diabeted CM appears to be a distinct entity but is a diagnosis that is made after exclusion of significant CAD, H/T or valvular disease. 
  • It is characterised by the presence of abnormal myocardial performance and/or structure in the absence of the above. 
  • Management of the diabetic risk factors and usual treatment of a dilated cardiopathypathy.